Visionary, data-driven Executive Clinical Research Professional respected for over 18 years leading global teams and managing innovative clinical projects at various private and public institutions. Experienced in overseeing up to $150M operational budgets and $50M project budgets, leading 35 direct and 160 indirect reports, and managing 75 vendors. Strategic leader who motivates teams to meet study timelines, clinical deliverables, and milestones within budget. Committed to providing continuous improvements through culture building and strategic initiatives while emphasizing collaboration to achieve client satisfaction.

In 2016, started and built a Contract Research Organization focused on training clinical research professionals, setting up clinical trial sites and managing clinical trials.

In 2017, founded NucleoBio Inc., a Biotech company, focused on developing a screening and diagnostic assay for Prostate Cancer.

Served as R&D consultant for big pharma and medical device companies to develop various drugs and medical devices.

Invited by NIH as SME to support efforts in the developing direct antigen tests for COVID-19 at the outbreak of the pandemic in 2020.

Recruited to serve on several boards advising business leaders in the pharma and biotech space.

Started out in real estate with single family before transitioning into multifamily.